1. Liquid Biopsies in Renal Cell Carcinoma—Recent Advances and Promising New Technologies for the Early Detection of Metastatic Disease
   Harini Lakshminarayanan et al, 2020, Frontiers in Oncology CrossRef
2. Circulating RNA in Kidney Cancer: What We Know and What We Still Suppose
   Alessandra Cinque et al, 2021, Genes CrossRef
3. Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
   Guiyun Cheng et al, 2020, Frontiers in Oncology CrossRef
4. Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors
   Yoshinori Hayashi et al, 2024, Molecular Oncology CrossRef
5. Current Trends in Liquid Biopsy Technology for Early Diagnosis of Metastatic Renal Cell Carcinoma
   Jeong Yoon Suh et al, 2022, The Korean Journal of Urological Oncology CrossRef
6. Bioinformatic analysis and validation of microRNA‐508‐3p as a protective predictor by targeting NR4A3/MEK axis in pulmonary arterial hypertension
   Yi Ma et al, 2021, Journal of Cellular and Molecular Medicine CrossRef
7. Identification of miR-885-5p as a Tumor Biomarker: Regulation of Cellular Function in Cervical Cancer
   Yuanqi Zu et al, 2021, Gynecologic and Obstetric Investigation CrossRef
8. A plasma 3-marker microRNA biosignature distinguishes spinal tuberculosis from other spinal destructive diseases and pulmonary tuberculosis
   Qiang Liang et al, 2023, Frontiers in Cellular and Infection Microbiology CrossRef
9. MicroRNAs as messengers of liver diseases: has the message finally been decrypted?
   Carlos J. Pirola et al, 2022, Clinical Science CrossRef
10. The combination of NDUFS1 with CD4+ T cell infiltration predicts favorable prognosis in kidney renal clear cell carcinoma
    Dong Wu et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
11. Role of microRNAs in renal cancer diagnostics
    A. B. Bondarenko et al, 2023, Russian Journal for Personalized Medicine CrossRef
12. MicroRNAs in Body Fluids: A More Promising Biomarker for Clear Cell Renal Cell Carcinoma
    Lei Shi et al, 2021, Cancer Management and Research CrossRef